HealthStream (NASDAQ:HSTM) Earns Overweight Rating from Analysts at Barclays

Barclays began coverage on shares of HealthStream (NASDAQ:HSTM – Free Report) in a report published on Wednesday morning, Briefing.com reports. The brokerage issued an overweight rating and a $32.00 target price on the technology company’s stock. HSTM has been the topic of a number of other reports. TheStreet raised HealthStream from a c+ rating to […]

Leave a Reply

Your email address will not be published.

Previous post Schoen: Can Haley or DeSantis get boost in Iowa?
Next post Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by Robert W. Baird